Status:
RECRUITING
Laparoscopic Interval Cytoreductive Surgery in Advance Ovarian Cancer
Lead Sponsor:
Instituto Nacional de Cancerologia de Mexico
Conditions:
Ovarian Neoplasms
Eligibility:
FEMALE
18-80 years
Phase:
NA
Brief Summary
This is a study that aims to demonstrate the non-inferiority of minimally invasive surgery versus open surgery, as an approach for patients with advanced ovarian cancer who received neoadjuvant chemot...
Eligibility Criteria
Inclusion
- Diagnosis of epithelial ovarian cancer (all subtypes of epithelial ovarian cancer) in stage III-IV
- Partial and complete response to treatment with QTNA after 3-4 cycles, evaluated by PET-CT imaging study, patients that the functional unit decides to incorporate into the project.
- Ca 125 which will have to be less than 200
- ECOG 0 to 2 without medical contraindication to perform surgery (≤ ASA 2 or ≤ Goldman 2).
Exclusion
- Partial response with persistence of ascites or pleural effusion.
- With unresectability criteria (multiple intrahepatic liver metastases, retroperitoneal lymph node conglomerates \>2cm above the renal lymph nodes, metastatic disease above the diaphragm, multiple intestinal involvement and mesentery retraction).
Key Trial Info
Start Date :
May 19 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2025
Estimated Enrollment :
33 Patients enrolled
Trial Details
Trial ID
NCT06883409
Start Date
May 19 2022
End Date
December 30 2025
Last Update
March 26 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Instituto Nacional de Cancerologia
México, Tlalpan, Mexico, 14080